Thus, NSDHL promotes breast cancer proliferation and metastasis through inhibition of TGF-βRII degradation, indicating that cholesterol upregulates TGF-βRII and subsequent TGF-β signaling. The gene discussed is NSDHL; the disease is breast carcinoma.